EN
HI
Valiant Laboratories share price chart
Valiant Laboratories Share Key Metrics
Volume
2.96 L
Market Cap
497.83 CR
LTQ@LTP
11@91.66
ATP
92.55
Var Margin
50 %
Circuit Range
87.08-96.24
Delivery %
71.89 %
Value
2.74 CR
ASM/GSM
No
Market Lot
1
Summary
VALIANTLAB stock price is ₹91.66 as of 21 Aug, 2026. The stock intraday movement has stayed between ₹88.40 and ₹95.00, while Valiant Laboratories share price 52 week high low is ₹49.51 & ₹95.10.
In terms of trading activity, VALIANTLAB share price has recorded a volume of 2,95,912 shares. The Valiant Laboratories has a market cap of ₹54312500. The stock’s Average Traded Price (ATP) stands at ₹92.55, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 11 @ ₹91.66.
The Valiant Laboratories upper circuit limit is ₹96.24 & The Valiant Laboratories lower circuit limit is ₹87.08, with a Value of ₹2.74 CR. The Delivery Percentage for the day is 71.89%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Valiant Laboratories Fundamentals
P/E Ratio
31.22
P/B Ratio
1.51
Div. Yield
0
Sector P/E
65.06
Sector P/B
3.33
Sec. Div. Yield
0.51
Valiant Laboratories Resistance and Support
Pivot 91.69
Resistance
First Resistance
94.98
Second Resistance
98.29
Third Resistance
101.58
Support
First Support
88.38
Second Support
85.09
Third Support
81.78
Valiant Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Aug 20 2026 | 94.8 | 91.66 | -0.32% | 95 | 88.4 |
| Wed Aug 19 2026 | 95.09 | 91.95 | 1.22% | 95.09 | 86.3 |
| Tue Aug 18 2026 | 90.84 | 90.84 | 4.99% | 90.84 | 88.26 |
Valiant Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-07-09 | Others |
| 2025-02-07 | Quarterly Results & Others |
| 2024-11-12 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
Valiant Laboratories News
Valiant Laboratories Ltd - 543998 - Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For Quarter Ended June 30, 2026.
Valiant Laboratories approved Q1 FY27 consolidated financial results. Consolidated revenue increased 146.21% YoY to ₹115.29 crores, and net profit grew 1058.9% YoY to ₹21.10 crores, driven by strong business performance in chemicals.
Aug 10 2026 20:24:20
Valiant Laboratories Ltd - 543998 - Board Meeting Intimation for Approval Of Financial Results For Quarter Ended June 30, 2026
Valiant Laboratories' Board of Directors is scheduled to meet on August 10, 2026, to consider and approve the standalone and consolidated financial results for the quarter ended June 30, 2026.
Aug 05 2026 14:55:14
Valiant Laboratories Management
| Name | Position |
|---|---|
| Mulesh M Savla | Non Executive Independent Director |
| Santosh S Vora | Managing Director |
Valiant Laboratories FAQs
The Buying Price of Valiant Laboratories share is 91.66 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Valiant Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Valiant Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Valiant Laboratories shares is 31.22. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Valiant Laboratories shares is 1.51. Useful to assess the stock's value relative to its book value.
To assess Valiant Laboratories’s valuation compare Sector P/E, P/B which are 65.06 & 3.33 with sector averages, along with growth rates and financial metrics.
The Market Cap of Valiant Laboratories is 497.83 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Valiant Laboratories share price is 95.10 & 49.51. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Valiant Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in VALIANTLAB
Or Download Choice FinX App
Invest in VALIANTLAB
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade